Owing to Increasing Technological Developments, Organ Preservation Solutions Market to Rise at 16.50% CAGR 2013-2019

Organ preservation solutions are used to preserve organs before transplantation procedure as these organs in external climate are vulnerable and also become dysfunctional once taken out from the human body. To preserve and maintain organs functionality for their further usage such as transplantation and research, organ preservation solutions are used. Increasing demand for organ transplantation procedures across the globe is expected to drive the growth of organ preservation solutions market. In addition, aging population will also propel the growth of organ preservation solutions market as the risk of organ failure in elderly people increases that augments the demand for organ transplants. Likewise, development of technologically advanced solutions for preserving organs will further accentuate the growth of organ preservation solutions market.

Download PDF Brochure of Report - http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1786

This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved. These solutions include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor). The market for these solutions has been extensively analyzed based on number of organ transplant, efficiency and application area. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

Based on the type of preservation techniques used to preserve organs, market has been segmented as hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques). The market for these technologies has been extensively analyzed based on number of organ transplant, compatibility with solution and organs, and cost. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for this segment. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, major events have also been discussed in the section that have boosted the growth of the market and expected to further propel the growth during the forecast period. Also, this section covers market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global ultrasound devices market. Market share (%) by revenue for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.